Harbor Investment Advisory, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Harbor Investment Advisory, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 21, 2023	SELL	$36.99 - $48.71 $7,915 - $10,423	-214 Reduced 24.51%	659 $26,000
Q2 2022 Jul 18, 2022	BUY	$45.8 - $85.4 $5,404 - $10,077	118 Added 15.63%	873 $52,000
Q2 2021 Jul 27, 2021	SELL	$92.19 - $115.71 $6,914 - $8,678	-75 Reduced 9.04%	755 $72,000
Q1 2021 Apr 16, 2021	SELL	$106.9 - $167.73 $7,803 - $12,244	-73 Reduced 8.08%	830 $95,000
Q4 2020 Feb 04, 2021	BUY	$84.4 - $177.39 $12,913 - $27,140	153 Added 20.4%	903 $125,000
Q3 2020 Oct 23, 2020	BUY	$72.98 - $90.0 $22,477 - $27,720	308 Added 69.68%	750 $62,000
Q1 2020 May 11, 2020	BUY	$33.8 - $62.9 $14,939 - $27,801	442 New	442 $20,000

326

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Harbor Investment Advisory, LLC with notifications on news.